Copyright Reports & Markets. All rights reserved.

Global Antiretroviral Drug Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Antiretroviral Drug Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Multi-Class Drugs Combination
      • 1.4.3 NRTI
      • 1.4.4 NNRTI
      • 1.4.5 Protease Inhibitors
      • 1.4.6 Other
    • 1.5 Market by Application
      • 1.5.1 Global Antiretroviral Drug Market Share by Application (2014-2025)
      • 1.5.2 Hospital
      • 1.5.3 Pharmaceutical Companies
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Antiretroviral Drug Market Size
    • 2.2 Antiretroviral Drug Growth Trends by Regions
      • 2.2.1 Antiretroviral Drug Market Size by Regions (2014-2025)
      • 2.2.2 Antiretroviral Drug Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Antiretroviral Drug Market Size by by Players
      • 3.1.1 Global Antiretroviral Drug Revenue by by Players (2014-2019)
      • 3.1.2 Global Antiretroviral Drug Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Antiretroviral Drug Market Concentration Ratio (CR5 and HHI)
    • 3.2 Antiretroviral Drug Key Players Head office and Area Served
    • 3.3 Key Players Antiretroviral Drug Product/Solution/Service
    • 3.4 Date of Enter into Antiretroviral Drug Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Antiretroviral Drug Market Size by Type (2014-2019)
    • 4.2 Global Antiretroviral Drug Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Antiretroviral Drug Market Size (2014-2019)
    • 5.2 Antiretroviral Drug Key Players in United States
    • 5.3 United States Antiretroviral Drug Market Size by Type
    • 5.4 United States Antiretroviral Drug Market Size by Application

    6 Europe

    • 6.1 Europe Antiretroviral Drug Market Size (2014-2019)
    • 6.2 Antiretroviral Drug Key Players in Europe
    • 6.3 Europe Antiretroviral Drug Market Size by Type
    • 6.4 Europe Antiretroviral Drug Market Size by Application

    7 China

    • 7.1 China Antiretroviral Drug Market Size (2014-2019)
    • 7.2 Antiretroviral Drug Key Players in China
    • 7.3 China Antiretroviral Drug Market Size by Type
    • 7.4 China Antiretroviral Drug Market Size by Application

    8 Japan

    • 8.1 Japan Antiretroviral Drug Market Size (2014-2019)
    • 8.2 Antiretroviral Drug Key Players in Japan
    • 8.3 Japan Antiretroviral Drug Market Size by Type
    • 8.4 Japan Antiretroviral Drug Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Antiretroviral Drug Market Size (2014-2019)
    • 9.2 Antiretroviral Drug Key Players in Southeast Asia
    • 9.3 Southeast Asia Antiretroviral Drug Market Size by Type
    • 9.4 Southeast Asia Antiretroviral Drug Market Size by Application

    10 India

    • 10.1 India Antiretroviral Drug Market Size (2014-2019)
    • 10.2 Antiretroviral Drug Key Players in India
    • 10.3 India Antiretroviral Drug Market Size by Type
    • 10.4 India Antiretroviral Drug Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Antiretroviral Drug Market Size (2014-2019)
    • 11.2 Antiretroviral Drug Key Players in Central & South America
    • 11.3 Central & South America Antiretroviral Drug Market Size by Type
    • 11.4 Central & South America Antiretroviral Drug Market Size by Application

    12 International Players Profiles

    • 12.1 Gilead Sciences
      • 12.1.1 Gilead Sciences Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Antiretroviral Drug Introduction
      • 12.1.4 Gilead Sciences Revenue in Antiretroviral Drug Business (2014-2019)
      • 12.1.5 Gilead Sciences Recent Development
    • 12.2 ViiV Healthcare
      • 12.2.1 ViiV Healthcare Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Antiretroviral Drug Introduction
      • 12.2.4 ViiV Healthcare Revenue in Antiretroviral Drug Business (2014-2019)
      • 12.2.5 ViiV Healthcare Recent Development
    • 12.3 Bristol-Myer Squibb
      • 12.3.1 Bristol-Myer Squibb Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Antiretroviral Drug Introduction
      • 12.3.4 Bristol-Myer Squibb Revenue in Antiretroviral Drug Business (2014-2019)
      • 12.3.5 Bristol-Myer Squibb Recent Development
    • 12.4 AbbVie
      • 12.4.1 AbbVie Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Antiretroviral Drug Introduction
      • 12.4.4 AbbVie Revenue in Antiretroviral Drug Business (2014-2019)
      • 12.4.5 AbbVie Recent Development
    • 12.5 Boehringer-Ingelheim
      • 12.5.1 Boehringer-Ingelheim Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Antiretroviral Drug Introduction
      • 12.5.4 Boehringer-Ingelheim Revenue in Antiretroviral Drug Business (2014-2019)
      • 12.5.5 Boehringer-Ingelheim Recent Development
    • 12.6 Johnson and Johnson
      • 12.6.1 Johnson and Johnson Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Antiretroviral Drug Introduction
      • 12.6.4 Johnson and Johnson Revenue in Antiretroviral Drug Business (2014-2019)
      • 12.6.5 Johnson and Johnson Recent Development
    • 12.7 Merck
      • 12.7.1 Merck Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Antiretroviral Drug Introduction
      • 12.7.4 Merck Revenue in Antiretroviral Drug Business (2014-2019)
      • 12.7.5 Merck Recent Development
    • 12.8 CIPLA
      • 12.8.1 CIPLA Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Antiretroviral Drug Introduction
      • 12.8.4 CIPLA Revenue in Antiretroviral Drug Business (2014-2019)
      • 12.8.5 CIPLA Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Tire-derived fuel (TDF) is composed of shredded scrap tires.
      In 2018, the global Antiretroviral Drug market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Antiretroviral Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antiretroviral Drug development in United States, Europe and China.

      The key players covered in this study
      Gilead Sciences
      ViiV Healthcare
      Bristol-Myer Squibb
      AbbVie
      Boehringer-Ingelheim
      Johnson and Johnson
      Merck
      CIPLA

      Market segment by Type, the product can be split into
      Multi-Class Drugs Combination
      NRTI
      NNRTI
      Protease Inhibitors
      Other

      Market segment by Application, split into
      Hospital
      Pharmaceutical Companies
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Antiretroviral Drug status, future forecast, growth opportunity, key market and key players.
      To present the Antiretroviral Drug development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Antiretroviral Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now